Label

How We Work

Grant

Back

Print

ModernaTX, Inc.


March 2019
to assess the feasibility of mRNA technology to deliver antibody combinations in selected neonates in low resource settings in order to reduce the impact of neonatal sepsis in this vulnerable population
$1,051,128
9
Discovery and Translational Sciences
Global Health
Cambridge, Massachusetts
http://www.modernatx.com

Visit Our Blog